Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126538651 | 12653865 | 1 | I | 20160804 | 20160816 | 20160816 | PER | US-ASTRAZENECA-2016SE84977 | ASTRAZENECA | 80.00 | YR | F | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126538651 | 12653865 | 1 | PS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | U | 19962 | MODIFIED-RELEASE TABLET | |||||||||
126538651 | 12653865 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | U | 0 | 25 | MG | TABLET | QD | ||||||
126538651 | 12653865 | 3 | SS | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
126538651 | 12653865 | 4 | SS | ALDACTONE | SPIRONOLACTONE | 1 | Unknown | U | 0 | ||||||||||
126538651 | 12653865 | 5 | C | CALCIUM CITRATE | CALCIUM CITRATE | 1 | Oral | 300.250, DAILY | 0 | TABLET | |||||||||
126538651 | 12653865 | 6 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5.0MG UNKNOWN | 0 | 5 | MG | ||||||||
126538651 | 12653865 | 7 | C | CARBIDOPA-LEVODOPA | CARBIDOPALEVODOPA | 1 | Oral | 25/100MG,THREE TIMES A DAY | 0 | TABLET | |||||||||
126538651 | 12653865 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
126538651 | 12653865 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
126538651 | 12653865 | 10 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
126538651 | 12653865 | 11 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 0 | 250 | MG | TABLET | QD | |||||||
126538651 | 12653865 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
126538651 | 12653865 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | 1000 | MG | TABLET | QD | |||||||
126538651 | 12653865 | 14 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126538651 | 12653865 | Drug hypersensitivity | |
126538651 | 12653865 | Heart rate increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126538651 | 12653865 | 2 | 20160527 | 0 |